Healthcare Global Enterprises Financial Statements

Healthcare Global Enterprises Profit & Loss Statement

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth (7.60) 31.50 18.70 19.80
Op profit growth (28) 42.10 13.20 23.90
EBIT growth (151) (48) 1.59 29.50
Net profit growth 81.30 (620) (7.40) (1,618)
Profitability ratios (%)        
OPM 12.10 15.50 14.30 15
EBIT margin (1.60) 2.81 7.07 8.26
Net profit margin (19) (9.80) 2.47 3.17
RoCE (0.90) 2.18 6 6.83
RoNW (9) (6) 1.08 1.29
RoA (2.80) (1.90) 0.52 0.65
Per share ratios ()        
EPS (18) (14) 1.95 2.69
Dividend per share -- -- -- --
Cash EPS (28) (29) (5.90) (4)
Book value per share 55.60 43 59.30 50.50
Valuation ratios        
P/E (11) (5.30) 150 85.70
P/CEPS (6.80) (2.60) (50) (57)
P/B 3.44 1.74 4.94 4.57
EV/EBIDTA 23.20 11.10 22.90 20.20
Payout (%)        
Dividend payout -- -- -- --
Tax payout (5.60) 5.79 (62) (34)
Liquidity ratios        
Debtor days 67.30 52.50 50.90 45
Inventory days 8.02 7.90 9.40 8.37
Creditor days (74) (74) (78) (79)
Leverage ratios        
Interest coverage 0.13 (0.20) (1.40) (2.50)
Net debt / equity 1.34 3.45 0.84 0.77
Net debt / op. profit 7.66 7.78 3.66 3.19
Cost breakup ()        
Material costs (24) (22) (23) (24)
Employee costs (19) (19) (19) (17)
Other costs (45) (44) (44) (43)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 1,009 1,092 831 700
yoy growth (%) (7.60) 31.50 18.70 19.80
Raw materials (240) (240) (190) (171)
As % of sales 23.80 22 22.80 24.40
Employee costs (196) (208) (158) (122)
As % of sales 19.40 19 19 17.40
Other costs (451) (476) (364) (302)
As % of sales 44.70 43.50 43.90 43.20
Operating profit 122 169 119 105
OPM 12.10 15.50 14.30 15
Depreciation (159) (148) (71) (57)
Interest expense (119) (138) (42) (23)
Other income 21.20 10.30 11.40 9.67
Profit before tax (135) (107) 16.40 34.80
Taxes 7.56 (6.20) (10) (12)
Tax rate (5.60) 5.79 (62) (34)
Minorities and other 27.60 18.80 3.59 (0.90)
Adj. profit (100) (94) 9.75 22.20
Exceptional items (93) -- 10.80 --
Net profit (193) (107) 20.50 22.20
yoy growth (%) 81.30 (620) (7.40) (1,618)
NPM (19) (9.80) 2.47 3.17
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax (135) (107) 16.40 34.80
Depreciation (159) (148) (71) (57)
Tax paid 7.56 (6.20) (10) (12)
Working capital 128 (46) (55) 55.40
Other operating items -- -- -- --
Operating cashflow (158) (308) (121) 21.60
Capital expenditure 1,214 1,404 197 (197)
Free cash flow 1,055 1,096 76.10 (175)
Equity raised 1,030 744 756 752
Investments 26.20 (30) 41.70 (42)
Debt financing/disposal 851 1,425 340 254
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 2,962 3,236 1,213 789
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 169 88.70 87.90 117
Preference capital -- -- -- --
Reserves 528 293 389 398
Net worth 697 381 477 515
Minority interest
Debt 977 1,347 658 464
Deferred tax liabilities (net) 4.28 6.98 3.97 3.77
Total liabilities 1,696 1,773 1,184 1,046
Fixed assets 1,412 1,692 1,123 1,002
Intangible assets
Investments 26.30 34.10 49.10 53.20
Deferred tax asset (net) 34.30 26.10 26.90 23.10
Net working capital 182 (11) (36) (60)
Inventories 21.10 23.30 26.80 24
Inventory Days 7.64 7.77 -- 10.60
Sundry debtors 187 186 157 128
Debtor days 67.50 62 -- 56.40
Other current assets 314 260 250 184
Sundry creditors (151) (210) (214) (164)
Creditor days 54.50 70 -- 72.20
Other current liabilities (189) (270) (256) (233)
Cash 40.90 32 20.90 28.80
Total assets 1,696 1,773 1,184 1,046
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Sep-2021 Jun-2021 Mar-2021 Dec-2020 Sep-2020
Gross Sales 351 322 297 273 247
Excise Duty -- -- -- -- --
Net Sales 351 322 297 273 247
Other Operating Income 0.71 0.72 1.01 1.07 1.06
Other Income 143 4.01 5.28 6.06 4.45
Total Income 495 327 303 280 252
Total Expenditure ** 292 272 343 245 218
PBIDT 203 55.20 (40) 35.20 34.50
Interest 23.20 26.40 25.90 28.70 27.20
PBDT 180 28.90 (66) 6.44 7.31
Depreciation 38 37.80 38.40 41.80 39.60
Minority Interest Before NP -- -- -- -- --
Tax 13.50 1.44 3.40 0.68 0.53
Deferred Tax 29.40 2.16 6.01 (1.30) (5.80)
Reported Profit After Tax 99 (13) (114) (35) (27)
Minority Interest After NP (4.10) (3) (12) (5.50) (4.70)
Net Profit after Minority Interest 103 (9.60) (102) (29) (22)
Extra-ordinary Items 97.70 -- (77) (8.60) --
Adjusted Profit After Extra-ordinary item 5.35 (9.60) (25) (21) (22)
EPS (Unit Curr.) 8.22 (0.80) (8.10) (2.30) (1.90)
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 125 125 125 125 125
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 57.80 17.10 (13) 12.90 14
PBDTM(%) 51.20 8.95 (22) 2.36 2.96
PATM(%) 28.20 (3.90) (38) (13) (11)
Open ZERO Brokerage Demat Account
Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity